{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:10:09Z","timestamp":1790619009993,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":3060,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s13311-014-0332-8","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T09:18:35Z","timestamp":1420708715000},"page":"317-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis\/Motor Neuron Disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Jeffrey","family":"Rosenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-014-0332-8_bib1","doi-asserted-by":"crossref","unstructured":"Jackson, C.E. and J. Rosenfeld, Motor neuron disease, in Physical Medicine & Rehabilitation Clinics of North America. 2001. p. 335-52, ix-x.","DOI":"10.1016\/S1047-9651(18)30073-1"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/14660820310011250","article-title":"Amyotrophic lateral sclerosis: a review of current concepts","volume":"4","author":"Strong","year":"2003","journal-title":"Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders"},{"issue":"6","key":"10.1007\/s13311-014-0332-8_bib3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/mus.24198","article-title":"Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research","volume":"49","author":"Su","year":"2014","journal-title":"Muscle & Nerve"},{"issue":"Suppl 1","key":"10.1007\/s13311-014-0332-8_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/21678421.2013.778554","article-title":"Mechanisms, models and biomarkers in amyotrophic lateral sclerosis","volume":"14","author":"Turner","year":"2013","journal-title":"Amyotrophic Lateral sclerosis & Frontotemporal Degeneration"},{"issue":"5","key":"10.1007\/s13311-014-0332-8_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cge.12117","article-title":"Clinical and genetic heterogeneity of amyotrophic lateral sclerosis","volume":"83","author":"Sabatelli","year":"2013","journal-title":"Clinical Genetics"},{"key":"10.1007\/s13311-014-0332-8_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0317167100001505","article-title":"The evidence for ALS as a multisystems disorder of limited phenotypic expression","volume":"28","author":"Strong","year":"2001","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00401-012-1022-4","article-title":"The genetics and neuropathology of amyotrophic lateral sclerosis","volume":"124","author":"Al-Chalabi","year":"2012","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/17482968.2011.580849","article-title":"Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS","volume":"12","author":"Sabatelli","year":"2011","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"8","key":"10.1007\/s13311-014-0332-8_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/jnnp.2011.241521","article-title":"Heterogeneity of pathological processes in amyotrophic lateral sclerosis? Journal of Neurology","volume":"82","author":"Vucic","year":"2011","journal-title":"Neurosurgery & Psychiatry"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pmr.2008.04.001","article-title":"Current and future directions in genomics of amyotrophic lateral sclerosis","volume":"19","author":"Ravits","year":"2008","journal-title":"Physical Medicine & Rehabilitation Clinics of North America"},{"key":"10.1007\/s13311-014-0332-8_bib11","doi-asserted-by":"crossref","unstructured":"Beghi, E., A. Chio, P. Couratier, et al., The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotrophic Lateral Sclerosis, 2011. 12(1): p. 1-10.","DOI":"10.3109\/17482968.2010.502940"},{"issue":"5","key":"10.1007\/s13311-014-0332-8_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/17482968.2011.649760","article-title":"Spinal cord markers in ALS: diagnostic and biomarker considerations","volume":"13","author":"Bede","year":"2012","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/156720212803530654","article-title":"Biomarkers in amyotrophic lateral sclerosis: is there a neurovascular pathway?","volume":"9","author":"Bhutani","year":"2012","journal-title":"Current Neurovascular Research"},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrneurol.2011.151","article-title":"Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations","volume":"7","author":"Bowser","year":"2011","journal-title":"Nature Reviews Neurology"},{"issue":"17","key":"10.1007\/s13311-014-0332-8_bib15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1212\/WNL.0b013e31828f18ac","article-title":"Cognitive changes predict functional decline in ALS: a populationbased longitudinal study","volume":"80","author":"Elamin","year":"2013","journal-title":"Neurology"},{"issue":"14","key":"10.1007\/s13311-014-0332-8_bib16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318214359f","article-title":"Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia","volume":"76","author":"Elamin","year":"2011","journal-title":"Neurology"},{"key":"10.1007\/s13311-014-0332-8_bib17","doi-asserted-by":"crossref","unstructured":"Hu, W.T., M. Shelnutt, A. Wilson, et al., Behavior matters\u2013cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS ONE [Electronic Resource], 2013. 8(2): p. e57584.","DOI":"10.1371\/journal.pone.0057584"},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib18","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1212\/01.wnl.0000188759.87240.8b","article-title":"The effects of executive and behavioral dysfunction on the course of ALS","volume":"65","author":"Olney","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s13311-014-0332-8_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/17482960802372371","article-title":"The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis","volume":"9","author":"Strong","year":"2008","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"10.1007\/s13311-014-0332-8_bib20","doi-asserted-by":"crossref","unstructured":"Strong, M.J., C. Lomen-Hoerth, R.J. Caselli, E.H. Bigio, and W. Yang, Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Annals of Neurology, 2003. 54(5).","DOI":"10.1002\/ana.10574"},{"issue":"5","key":"10.1007\/s13311-014-0332-8_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/jnnp.58.5.541","article-title":"Inter-relation between \u201cclassic\u201d motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study","volume":"58","author":"Talbot","year":"1995","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1007\/s13311-014-0332-8_bib22","doi-asserted-by":"crossref","unstructured":"Byrne, S., M. Elamin, P. Bede, et al., Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.[Erratum appears in Lancet Neurol. 2012 May;11(5):388]. Lancet Neurology, 2012. 11(3): p. 232-40.","DOI":"10.1016\/S1474-4422(12)70014-5"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"issue":"6","key":"10.1007\/s13311-014-0332-8_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00401-011-0907-y","article-title":"Clinical and neuropathologic heterogeneity of c9FTD\/ALS associated with hexanucleotide repeat expansion in C9ORF72","volume":"122","author":"Murray","year":"2011","journal-title":"Acta Neuropathologica"},{"key":"10.1007\/s13311-014-0332-8_bib25","doi-asserted-by":"crossref","unstructured":"Ashworth, N.L., L.E. Satkunam, and D. Deforge, Treatment for spasticity in amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database of Systematic Reviews, 2012. 2: p. CD004156.","DOI":"10.1002\/14651858.CD004156.pub4"},{"key":"10.1007\/s13311-014-0332-8_bib26","doi-asserted-by":"crossref","unstructured":"Baldinger, R., H.D. Katzberg, and M. Weber, Treatment for cramps in amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database of Systematic Reviews, 2012. 4: p. CD004157.","DOI":"10.1002\/14651858.CD004157.pub2"},{"key":"10.1007\/s13311-014-0332-8_bib27","doi-asserted-by":"crossref","unstructured":"Young, C.A., C. Ellis, J. Johnson, S. Sathasivam, and N. Pih, Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis. Cochrane Database of Systematic Reviews, 2011(5): p. CD006981.","DOI":"10.1002\/14651858.CD006981.pub2"},{"key":"10.1007\/s13311-014-0332-8_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-4-10","article-title":"Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency","volume":"4","author":"Carratu","year":"2009","journal-title":"Orphanet Journal Of Rare Diseases"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jnnp.72.2.275","article-title":"Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis","volume":"72","author":"Marquardt","year":"2002","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004150050578","article-title":"Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis","volume":"247","author":"Hardiman","year":"2000","journal-title":"Journal of Neurology."},{"key":"10.1007\/s13311-014-0332-8_bib31","doi-asserted-by":"crossref","unstructured":"Radunovic, A., D. Annane, M.K. Rafiq, and N. Mustfa, Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database of Systematic Reviews, 2013. 3: p. CD004427.","DOI":"10.1002\/14651858.CD004427.pub3"},{"key":"10.1007\/s13311-014-0332-8_bib32","doi-asserted-by":"crossref","unstructured":"Georgoulopoulou, E., N. Fini, M. Vinceti, et al., The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: a population based study in Modena, Italy. Amyotrophic Lateral sclerosis & Frontotemporal Degeneration, 2013. 14(5-6): p. 338-45.","DOI":"10.3109\/21678421.2013.763281"},{"key":"10.1007\/s13311-014-0332-8_bib33","doi-asserted-by":"crossref","unstructured":"Katzberg, H.D. and M. Benatar, Enteral tube feeding for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database of Systematic Reviews, 2011(1): p. CD004030.","DOI":"10.1002\/14651858.CD004030.pub3"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7861\/clinmedicine.10-3-252","article-title":"Motor neurone disease: a practical update on diagnosis and management","volume":"10","author":"Wood-Allum","year":"2010","journal-title":"Clinical Medicine"},{"issue":"30","key":"10.1007\/s13311-014-0332-8_bib35","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/092986707782793862","article-title":"The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure","volume":"14","author":"Beghi","year":"2007","journal-title":"Current Medicinal Chemistry"},{"key":"10.1007\/s13311-014-0332-8_bib36","doi-asserted-by":"crossref","unstructured":"Rosenfeld, J. and M. Swash, What's in a name? Lumping or splitting ALS, PLS, PMA and the other motor neuron diseases. Neurology, 2006. 66(draft).","DOI":"10.1212\/01.wnl.0000205597.62054.db"},{"issue":"10","key":"10.1007\/s13311-014-0332-8_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","article-title":"ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration","volume":"73","author":"Ravits","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-014-0332-8_bib38","doi-asserted-by":"crossref","unstructured":"Turner, M.R., J. Scaber, J.A. Goodfellow, et al., The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 2010. 294(1-2): p. 81-5.","DOI":"10.1016\/j.jns.2010.03.028"},{"key":"10.1007\/s13311-014-0332-8_bib39","doi-asserted-by":"crossref","unstructured":"Pringle, C.E., A.J. Hudson, D.G. Munoz, et al., Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain, 1992. 115(Pt 2): p. 495-520.","DOI":"10.1093\/brain\/115.2.495"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archneur.64.2.232","article-title":"Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up","volume":"64","author":"Tartaglia","year":"2007","journal-title":"Archives of Neurology"},{"key":"10.1007\/s13311-014-0332-8_bib41","first-page":"293","article-title":"El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"ALS and Other Motor Neuron Diseases"},{"issue":"8","key":"10.1007\/s13311-014-0332-8_bib42","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archneur.57.8.1171","article-title":"Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study","volume":"57","author":"Traynor","year":"2000","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1007\/s13311-014-0332-8_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/17482961003777462","article-title":"Sensitivity and specificity of the \u2018Awaji\u2019 electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS","volume":"11","author":"Boekestein","year":"2010","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"1","key":"10.1007\/s13311-014-0332-8_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17482960802521126","article-title":"Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis","volume":"10","author":"Carvalho","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib45","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneurol.2012.254","article-title":"Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review","volume":"69","author":"Costa","year":"2012","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mus.22299","article-title":"Fasciculation potentials in amyotrophic lateral sclerosis and the diagnostic yield of the Awaji algorithm","volume":"45","author":"Higashihara","year":"2012","journal-title":"Muscle & Nerve"},{"key":"10.1007\/s13311-014-0332-8_bib47","doi-asserted-by":"crossref","unstructured":"Strong, M.J., G.M. Grace, M. Freedman, et al., Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.[Erratum appears in Amyotroph Lateral Scler. 2009 Aug;10(4):252]. Amyotrophic Lateral Sclerosis, 2009. 10(3): p. 131-46.","DOI":"10.1080\/17482960802654364"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib48","first-page":"105","article-title":"Motor neuron disease: Classification and nomenclature","volume":"1","author":"Swash","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"6","key":"10.1007\/s13311-014-0332-8_bib49","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1468-1331.2011.03616.x","article-title":"Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis","volume":"19","author":"Gargiulo-Monachelli","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"19","key":"10.1007\/s13311-014-0332-8_bib50","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/01.wnl.0000261045.57095.56","article-title":"Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem","volume":"68","author":"Ravits","year":"2007","journal-title":"Neurology"},{"issue":"19","key":"10.1007\/s13311-014-0332-8_bib51","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/01.wnl.0000260965.20021.47","article-title":"Focality of upper and lower motor neuron degeneration at the clinical onset of ALS","volume":"68","author":"Ravits","year":"2007","journal-title":"Neurology"},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib52","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/jnnp-2011-300141","article-title":"Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis","volume":"82","author":"Fujimura-Kiyono","year":"2011","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1007\/s13311-014-0332-8_bib53","doi-asserted-by":"crossref","unstructured":"Sekiguchi, T., T. Kanouchi, K. Shibuya, et al., Spreading of amyotrophic lateral sclerosis lesions\u2013multifocal hits and local propagation? Journal of Neurology, Neurosurgery & Psychiatry, 2014. 85(1): p. 85-91.","DOI":"10.1136\/jnnp-2013-305617"},{"key":"10.1007\/s13311-014-0332-8_bib54","doi-asserted-by":"crossref","unstructured":"Balendra R, Jones A, Jivraj N, and e. al, Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. J Neurol Neurosurg Psychiatry, 2014. 24(doi 10.1136\/jmp-213-306865).","DOI":"10.1136\/jnnp-2013-306865"},{"issue":"Pt 3","key":"10.1007\/s13311-014-0332-8_bib55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/brain\/awr351","article-title":"A proposed staging system for amyotrophic lateral sclerosis","volume":"135","author":"Roche","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/14660820050515403","article-title":"Motor neuron disease: classification and nomenclature","volume":"1","author":"Swash","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders"},{"issue":"7","key":"10.1007\/s13311-014-0332-8_bib57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study","volume":"82","author":"Chio","year":"2011","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1007\/s13311-014-0332-8_bib58","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/jnnp.65.6.950","article-title":"Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis","volume":"65","author":"Hu","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib59","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1440-1789.2009.01084.x","article-title":"Pseudopolyneuritic form of ALS revisited: clinical and pathological heterogeneity","volume":"30","author":"Kobayashi","year":"2010","journal-title":"Neuropathology"},{"key":"10.1007\/s13311-014-0332-8_bib60","doi-asserted-by":"crossref","unstructured":"Lambrechts, D., W. Robberecht, and P. Carmeliet, Heterogeneity in motoneuron disease. p. 536-44, 2007 Oct.","DOI":"10.1016\/j.tins.2007.07.002"},{"key":"10.1007\/s13311-014-0332-8_bib61","doi-asserted-by":"crossref","unstructured":"Kasper, E., M. Wegrzyn, I. Marx, et al., Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy's disease. Amyotrophic Lateral sclerosis & Frontotemporal Degeneration, 2014. 15(1-2): p. 15-20.","DOI":"10.3109\/21678421.2013.837927"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/jnnp.2009.204446","article-title":"Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy","volume":"82","author":"Raaphorst","year":"2011","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib63","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00415-009-5212-5","article-title":"Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled neuropsychological study of 20 patients","volume":"256","author":"Soukup","year":"2009","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1155\/2013\/126010","article-title":"The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria","volume":"27","author":"Consonni","year":"2013","journal-title":"Behavioural Neurology"},{"key":"10.1007\/s13311-014-0332-8_bib65","doi-asserted-by":"crossref","unstructured":"Raaphorst, J., M. de Visser, W.H.J.P. Linssen, R.J. de Haan, and B. Schmand, The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis. Amyotrophic Lateral Sclerosis, 2010. 11(1-2): p. 27-37.","DOI":"10.3109\/17482960802645008"},{"issue":"1","key":"10.1007\/s13311-014-0332-8_bib66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/17482960601044106","article-title":"Detecting neurobehavioral changes in amyotrophic lateral sclerosis","volume":"8","author":"Grossman","year":"2007","journal-title":"Amyotrophic Lateral Sclerosise"},{"issue":"1","key":"10.1007\/s13311-014-0332-8_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/17482968.2010.520718","article-title":"How common are behavioural changes in amyotrophic lateral sclerosis?","volume":"12","author":"Lillo","year":"2011","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archneur.64.4.530","article-title":"Continuum of frontal lobe impairment in amyotrophic lateral sclerosis","volume":"64","author":"Murphy","year":"2007","journal-title":"Archives of Neurology"},{"key":"10.1007\/s13311-014-0332-8_bib69","doi-asserted-by":"crossref","unstructured":"Cerami, C., A. Dodich, N. Canessa, et al., Emotional empathy in amyotrophic lateral sclerosis: a behavioural and voxel-based morphometry study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2014. 15(1-2): p. 21-29.","DOI":"10.3109\/21678421.2013.785568"},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib70","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1093\/brain\/awq254","article-title":"Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis","volume":"133","author":"Meier","year":"2010","journal-title":"Brain"},{"key":"10.1007\/s13311-014-0332-8_bib71","doi-asserted-by":"crossref","unstructured":"Oh, S.-i., A. Park, H.-J. Kim, et al., Spectrum of Cognitive Impairment in Korean ALS Patients without Known Genetic Mutations. . PLoS ONE [Electronic Resource], 2014. 9(2): p. e87163.","DOI":"10.1371\/journal.pone.0087163"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.38.3.405","article-title":"Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis","volume":"38","author":"Andres","year":"1988","journal-title":"Neurology"},{"issue":"5","key":"10.1007\/s13311-014-0332-8_bib73","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/WNL.46.5.1442","article-title":"Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS","volume":"46","author":"McGuire","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib74","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jnnp.57.3.326","article-title":"Accuracy, reproducibility, and variability of handheld dynamometry in motor neuron disease","volume":"57","author":"Goonetilleke","year":"1994","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1007\/s13311-014-0332-8_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/17482968.2010.531742","article-title":"Neurophysiological index as a biomarker for ALS progression: validity of mixed effects models","volume":"12","author":"Cheah","year":"2011","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1097-4598(199702)20:2<179::AID-MUS7>3.0.CO;2-9","article-title":"A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis","volume":"20","author":"Felice","year":"1997","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0b013e318225aabf","article-title":"Multipoint incremental motor unit number estimation as an outcome measure in ALS","volume":"77","author":"Shefner","year":"2011","journal-title":"Neurology"},{"issue":"10","key":"10.1007\/s13311-014-0332-8_bib78","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.39.10.973","article-title":"Multiple point electrical stimulation of ulnar and median nerves","volume":"39","author":"Kadrie","year":"1976","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(05)70042-9","article-title":"Assessment of disease progression in motor neuron disease","volume":"4","author":"Winhammar","year":"2005","journal-title":"Lancet Neurology"},{"key":"10.1007\/s13311-014-0332-8_bib80","doi-asserted-by":"crossref","unstructured":"Cedarbaum, J.M., N. Stambler, E. Malta, et al., The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences, 1999. 169(1-2): p. 13-21.","DOI":"10.1016\/S0022-510X(99)00210-5"},{"issue":"12","key":"10.1007\/s13311-014-0332-8_bib81","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/jnnp-2012-304701","article-title":"Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis","volume":"84","author":"Franchignoni","year":"2013","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"7","key":"10.1007\/s13311-014-0332-8_bib82","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/01.wnl.0000243812.25517.87","article-title":"Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS","volume":"67","author":"Gordon","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology"},{"issue":"8","key":"10.1007\/s13311-014-0332-8_bib84","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.clinph.2011.11.262","article-title":"Muscle ultrasonography: a diagnostic tool for amyotrophic lateral sclerosis","volume":"123","author":"Arts","year":"2012","journal-title":"Clinical Neurophysiology"},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib85","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.clinph.2007.08.004","article-title":"Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials","volume":"118","author":"Rutkove","year":"2007","journal-title":"Clinical Neurophysiology"},{"issue":"5","key":"10.1007\/s13311-014-0332-8_bib86","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(11)70049-7","article-title":"Towards a neuroimaging biomarker for amyotrophic lateral sclerosis","volume":"10","author":"Turner","year":"2011","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jnnp-2013-305494","article-title":"Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis","volume":"85","author":"Puentes","year":"2014","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"9","key":"10.1007\/s13311-014-0332-8_bib88","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/humu.22157","article-title":"ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics","volume":"33","author":"Abel","year":"2012","journal-title":"Human Mutation"},{"issue":"1","key":"10.1007\/s13311-014-0332-8_bib89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nature Neuroscience"},{"issue":"5918","key":"10.1007\/s13311-014-0332-8_bib90","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"10.1007\/s13311-014-0332-8_bib91","unstructured":"Andersen, P., M. Morita, and R. Brown, Genetics of amyotrophic lateral sclerosis: An overview, in Amyotrophic Lateral Sclerosis, R. Brown, V. Meininger, and M. Swash, Editors. 2000, Martin-Dunitz: London. p. 223-250."},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib92","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","article-title":"Clinical genetics of amyotrophic lateral sclerosis: what do we really know?","volume":"7","author":"Andersen","year":"2011","journal-title":"Nature Reviews Neurology"},{"issue":"Suppl 1","key":"10.1007\/s13311-014-0332-8_bib93","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/21678421.2013.778571","article-title":"Genetic and epigenetic studies of amyotrophic lateral sclerosis","volume":"14","author":"Al-Chalabi","year":"2013","journal-title":"Amyotrophic Lateral sclerosis & Frontotemporal Degeneration"},{"issue":"8","key":"10.1007\/s13311-014-0332-8_bib94","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa070174","article-title":"Whole-genome analysis of sporadic amyotrophic lateral sclerosis","volume":"357","author":"Dunckley","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib95","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1474-4422(07)70037-6","article-title":"Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data","volume":"6","author":"Schymick","year":"2007","journal-title":"Lancet Neurology"},{"issue":"22","key":"10.1007\/s13311-014-0332-8_bib96","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1073\/pnas.0812937106","article-title":"Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis","volume":"106","author":"Landers","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1007\/s13311-014-0332-8_bib97","doi-asserted-by":"crossref","unstructured":"Consortium, A., K.B. Ahmeti, S. Ajroud-Driss, et al., Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. Neurobiology of Aging, 2013. 34(1): p. 357.e7-19.","DOI":"10.1016\/j.neurobiolaging.2012.07.017"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-014-1251-9","article-title":"The widening spectrum of C9ORF72-related disease; genotype\/phenotype correlations and potential modifiers of clinical phenotype","volume":"127","author":"Cooper-Knock","year":"2014","journal-title":"Acta Neuropathologica"},{"issue":"11","key":"10.1007\/s13311-014-0332-8_bib99","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","article-title":"The epidemiology of ALS: a conspiracy of genes, environment and time","volume":"9","author":"Al-Chalabi","year":"2013","journal-title":"Nature Reviews Neurology"},{"key":"10.1007\/s13311-014-0332-8_bib100","doi-asserted-by":"crossref","unstructured":"Droppelmann, C., D. Campos-Melo, M. Ishtiaq, K. Volkening, and M. Strong, RNA metabolism in ALS: When normal processes become pathological Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2014. 15(5-6): p. 321-336.","DOI":"10.3109\/21678421.2014.881377"},{"key":"10.1007\/s13311-014-0332-8_bib101","doi-asserted-by":"crossref","unstructured":"Strong, M.J., The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). Journal of the Neurological Sciences, 2010. 288(1-2): p. 1-12.","DOI":"10.1016\/j.jns.2009.09.029"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib102","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","article-title":"Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis","volume":"74","author":"Desport","year":"2001","journal-title":"American Journal of Clinical Nutrition."},{"issue":"8","key":"10.1007\/s13311-014-0332-8_bib103","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.nmd.2006.04.005","article-title":"135th ENMC International Workshop: nutrition in amyotrophic lateral sclerosis 18-20 of March 2005, Naarden","volume":"16","author":"Ludolph","year":"2006","journal-title":"The Netherlands. Neuromuscular Disorders."},{"key":"10.1007\/s13311-014-0332-8_bib104","doi-asserted-by":"crossref","unstructured":"Desport, J.C., F. Torny, M. Lacoste, P.M. Preux, and P. Couratier, Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegenerative Diseases., 2005. 2(3-4): p. 202-7.","DOI":"10.1159\/000089626"},{"issue":"6","key":"10.1007\/s13311-014-0332-8_bib105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0148607104028006442","article-title":"Standard equations are not accurate in assessing resting energy expenditure in patients with amyotrophic lateral sclerosis","volume":"28","author":"Sherman","year":"2004","journal-title":"J. Parenteral Enteral Nutrition"},{"issue":"6","key":"10.1007\/s13311-014-0332-8_bib106","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<874::AID-MUS5>3.0.CO;2-U","article-title":"Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis","volume":"23","author":"Armon","year":"2000","journal-title":"Muscle & Nerve"},{"key":"10.1007\/s13311-014-0332-8_bib107","doi-asserted-by":"crossref","unstructured":"Cameron, A. and J. Rosenfeld, Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders. 2002: p. 631-43.","DOI":"10.1097\/00075197-200211000-00005"},{"key":"10.1007\/s13311-014-0332-8_bib108","unstructured":"Camu, W., J. Z, C. J, C. C, and B. F. Early Percutaneous Endoscopic Gastrostomy in ALS is a Major FActor Survival for Improving Survival. in 53rd Annual Meeting of the American Academy of Neurology. 2001. Philadelphia, PA."},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/14660820050515386","article-title":"Nutritional assessment and survival in ALS patients","volume":"1","author":"Desport","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders"},{"issue":"5","key":"10.1007\/s13311-014-0332-8_bib110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","article-title":"Nutritional Status is a prognostic for survival in ALS patients","volume":"53","author":"Desport","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-014-0332-8_bib111","first-page":"46","article-title":"Protein-calorie malnutrition and involuntary weight loss: the role of aggressive nutritional intervention in wound healing","volume":"45","author":"Himes","year":"1999","journal-title":"Ostomy\/Wound Healing"},{"issue":"1","key":"10.1007\/s13311-014-0332-8_bib112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/17482968.2012.690419","article-title":"The natural history of motor neuron disease: assessing the impact of specialist care","volume":"14","author":"Aridegbe","year":"2013","journal-title":"Amyotrophic Lateral sclerosis & Frontotemporal Degeneration"},{"issue":"15","key":"10.1007\/s13311-014-0332-8_bib113","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.0b013e3181bc01a4","volume":"73","author":"Miller","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1007\/s13311-014-0332-8_bib114","first-page":"455","article-title":"F.J., C. Oreja Guevara, I. Sanz Gallego, et al., Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit","volume":"26","author":"de Rivera","year":"2011","journal-title":"Neurologia"},{"issue":"10","key":"10.1007\/s13311-014-0332-8_bib115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF00866922","article-title":"Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis","volume":"242","author":"Mazzini","year":"1995","journal-title":"Journal of Neurology"},{"issue":"15","key":"10.1007\/s13311-014-0332-8_bib116","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","article-title":"Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"73","author":"Miller","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-014-0332-8_bib117","series-title":"Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines","author":"Andersen","year":"2007"},{"key":"10.1007\/s13311-014-0332-8_bib118","doi-asserted-by":"crossref","unstructured":"Trail, M., N.D. Nelson, J.N. Van, S.H. Appel, and E.C. Lai, A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. Journal of the Neurological Sciences., 2003. 209(1-2): p. 79-85.","DOI":"10.1016\/S0022-510X(03)00003-0"},{"key":"10.1007\/s13311-014-0332-8_bib119","doi-asserted-by":"crossref","unstructured":"Chio, A., G. Mora, M. Leone, et al., Early symptom progression rate is related to ALS outcome: a prospective population-based study.[see comment]. 2002: p. 99-103.","DOI":"10.1212\/WNL.59.1.99"},{"key":"10.1007\/s13311-014-0332-8_bib120","doi-asserted-by":"crossref","unstructured":"Shaw, A.S., M.A. Ampong, A. Rio, et al., Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre. 2006: p. 16-21.","DOI":"10.1080\/14660820510012013"},{"key":"10.1007\/s13311-014-0332-8_bib121","doi-asserted-by":"crossref","unstructured":"Strong, M.J., A. Rowe, and R.N. Rankin, Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 1999: p. 128-132.","DOI":"10.1016\/S0022-510X(99)00235-X"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib122","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/14660820410020349","article-title":"Nutritional management in MND\/ALS patients: an evidence based review","volume":"5","author":"Heffernan","year":"2004","journal-title":"Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders."},{"key":"10.1007\/s13311-014-0332-8_bib123","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","article-title":"Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"73","author":"Miller","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib124","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jnnp.2003.020347","article-title":"Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS","volume":"75","author":"Chio","year":"2004","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1007\/s13311-014-0332-8_bib125","unstructured":"Pacicco, T.J., S. Lindblom, and J. Rosenfeld. Enhancing PEG Tube Placement: A New Device to Maintain Respiratory Function During Endoscopy in ALS Patients. in International Motor Neuron Disease Symposium. 2005. Dubiln, Ireland."},{"issue":"1","key":"10.1007\/s13311-014-0332-8_bib126","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-510X(99)00045-3","article-title":"Bipap improves survival and rate of pulmonary function decline in patients with ALS [see comments]","volume":"164","author":"Kleopa","year":"1999","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1007\/s13311-014-0332-8_bib127","doi-asserted-by":"crossref","unstructured":"Pinto, A.C., T. Evangelista, M. Carvalho, M.A. Alves, and M.L. Sales Luis, Respiratory assistance with a non-invasive ventilator (Bipap) in MND\/ALS patients: survival rates in a controlled trial. Journal of the Neurological Sciences, 1995. 129(Suppl): p. 19-26.","DOI":"10.1016\/0022-510X(95)00052-4"},{"issue":"4","key":"10.1007\/s13311-014-0332-8_bib128","first-page":"338","article-title":"Amyotrophic lateral sclerosis","volume":"76","author":"Hanayama","year":"1997","journal-title":"Successful treatment of mucous plugging by mechanical insufflation-exsufflation. American Journal of Physical Medicine & Rehabilitation"},{"issue":"1","key":"10.1007\/s13311-014-0332-8_bib129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/17482968.2010.535541","article-title":"A comparison of assisted cough techniques in stable patients with severe respiratory insufficiency due to amyotrophic lateral sclerosis","volume":"12","author":"Senent","year":"2011","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"10.1007\/s13311-014-0332-8_bib130","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1164\/ajrccm.150.4.7921452","article-title":"Comparison of high frequency chest compression and conventional chest physiotherapy I hospitalized patients with cystic fibrosis","volume":"150","author":"Arens","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s13311-014-0332-8_bib131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ppul.1950110314","article-title":"The long term effect of high frequency chest compression therapy on pulmonary complications of cystic fibrosis","volume":"11","author":"Warwick","year":"1991","journal-title":"Pediatr Pumonol"},{"key":"10.1007\/s13311-014-0332-8_bib132","doi-asserted-by":"crossref","unstructured":"Anagnostou, E., M. Rentzos, T. Alexakis, et al., Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.[Erratum appears in Muscle Nerve. 2013 Jul;48(1):155 Note: Evangelos, Anagnostou [corrected to Anagnostou, Evangelos]; Michael, Rentzos [corrected to Rentzos, Michael]; Theodoros, Alexakis [corrected to Alexakis, Theodoros]; Vasiliki, Zouvelou [corrected to Zouvelou, Vasiliki]; Thomas, Zambelis [corrected to Zambelis, Thomas]; Ioannis, Evdokimidis [corrected to Evdokimidis, Ioannis]]. Muscle & Nerve, 2013. 47(2): p. 276-8.","DOI":"10.1002\/mus.23692"},{"issue":"2","key":"10.1007\/s13311-014-0332-8_bib133","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle & Nerve"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-014-0332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-014-0332-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-014-0332-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:43:23Z","timestamp":1761806603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923008279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1878747923008279"],"URL":"https:\/\/doi.org\/10.1007\/s13311-014-0332-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis\/Motor Neuron Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-014-0332-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}